Interactions of cell penetrating peptide Tat with model membranes: A biophysical study

Biochemical and Biophysical Research Communications

Volumn 363, Issue 1, 2007, Pages 178-182

  Dennison, Sarah R ^a   Baker, Rachael D ^b   Nicholl, Iain D ^b   Phoenix, David A ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Cell penetrating; Isotherm; Lipid monolayer; Tat peptide

Indexed keywords

PROTEIN P10; TRANSACTIVATOR PROTEIN; TRANSACTIVATOR PROTEIN 48 60; UNCLASSIFIED DRUG;

ARTICLE; BIOPHYSICS; CELL ACTIVITY; CELL INTERACTION; CELL MEMBRANE; DRUG SOLUBILITY; DRUG SYNTHESIS; GENE CONSTRUCT; GENE LOCATION; GENETIC TRANSDUCTION; PRIORITY JOURNAL;

BINDING SITES; BIOMIMETICS; BIOPHYSICS; LIPID BILAYERS; MEMBRANE FLUIDITY; MEMBRANES, ARTIFICIAL; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS; PROTEIN BINDING; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34548760754     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.162     Document Type: Article

References (37)

1. Langel U. Preface. In: Langel U. (Ed). Handbook of Cell-Penetrating Peptides (2007), CRC/Taylor & Francis, Boca Raton
2. Frankel A.D., and Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 (1988) 1189-1193
3. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., and Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91 (1994) 664-668
4. Sabatier J.M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., and Bahraoui E. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65 (1991) 961-967
5. Abes S., Richard J.-P., Thierry A., Clair P., and Lebleu B. Tat-derived cell-pentrating peptides: Discovery, mechanism of cell uptake, and applications to the delivery of oligonucleotides. In: Langel U. (Ed). Handbook of Cell-Penetrating Peptides (2007), CRC/Taylor & Francis, Boca Raton 29-42
6. Joliot A., and Prochiantz A. Transduction peptides: from technology to physiology. Nat. Cell Biol. 6 (2004) 189-196
7. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
8. Stallmann H.P., Faber C., Nieuw Amerongen A.V., and Wuisman P.I. Antimicrobial peptides: review of their application in musculoskeletal infections. Injury 37 Suppl. 2 (2006) S34-S40
9. Kaplan I.M., Wadia J.S., and Dowdy S.F. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Control. Release 102 (2005) 247-253
10. Potocky T.B., Menon A.K., and Gellman S.H. Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 278 (2003) 50188-50194
11. Belting M., Sandgren S., and Wittrup A. Nuclear delivery of macromolecules: barriers and carriers. Adv. Drug Deliv. Rev. 57 (2005) 505-527
12. Sandgren S., Cheng F., and Belting M. Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. J. Biol. Chem. 277 (2002) 38877-38883
13. Ziegler A., and Seelig J. Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters. Biophys. J. 86 (2004) 254-263
14. Console S., Marty C., Garcia-Echeverria C., Schwendener R., and Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278 (2003) 35109-35114
15. Brooks H., Lebleu B., and Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Deliv. Rev. 57 (2005) 559-577
16. Thoren P.E., Persson D., Isakson P., Goksor M., Onfelt A., and Norden B. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307 (2003) 100-107
17. Thoren P.E., Persson D., Lincoln P., and Norden B. Membrane destabilizing properties of cell-penetrating peptides. Biophys. Chem. 114 (2005) 169-179
18. Esbjorner E.K., Graslund A., and Norden B. Membrane interactions of cell-penetrating peptides. In: Langel U. (Ed). Handbook of Cell-Penetrating Peptides (2007), CRC/Taylor & Francis, Boca Raton 109-137
19. Kovvali G., Shiff S., Telang N., Das K., Kohgo Y., Narayan S., and Li H. Carcinogenesis: the more we seek to know the more we need to know-challenges in the post genomic era. J. Carcinog. 2 (2003) 1
20. Baker R.D., Howl J., and Nicholl I.D. A sychnological cell penetrating peptide mimic of p21(WAF1/CIP1) is pro-apoptogenic. Peptides 28 (2007) 731-740
21. Brandenburg K., Harris F., Dennison S., Seydel U., and Phoenix D. Domain V of m-calpain shows the potential to form an oblique-orientated alpha-helix, which may modulate the enzyme's activity via interactions with anionic lipid. Eur. J. Biochem. 269 (2002) 5414-5422
22. Demel R.A. Model membrane monolayers-description of use and interaction. Methods Enzymol. 32 (1974) 539-545
23. Marshall S.H., and Arenas G. Antimicrobial peptides: a natural alternative to chemical antibiotics and a potential for applied biotechnology. Electron. J. Biotechnol. [online] 6 (2003)
24. Ronzon F., Desbat B., Chauvet J.-P., and Roux B. Penetration of a GPI-anchored protein into phospholipid monolayers spread at the air/water interface. Colloids Surf. B: Biointerfaces 23 (2002) 365-373
25. Birdi K.S. Self-Assembly Monolayer Structures of Lipids and Macromolecules at Interfaces (1999), Kluwer Academic Publishers
26. Maget-Dana R. The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their interactions with lipid membranes. Biochim. Biophys. Acta 1462 (1999) 109-140
27. Davies J.T., and Rideal E.K. Interfacial Phenomena. second ed. (1963), Academic Press, New York
28. Blume A. A comparative study of the phase transitions of phospholipid bilayers and monolayers. Biochim. Biophys. Acta 557 (1979) 32-44
29. Seelig A. Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim. Biophys. Acta 899 (1987) 196-204
30. Dennison S.R., Harris F., and Phoenix D.A. The interactions of aurein 1.2 with cancer cell membranes. Biophys. Chem. 127 (2007) 78-83
31. Harris F., Brandenburg K., Seydel U., and Phoenix D. Investigations into the mechanisms used by the C-terminal anchors of Escherichia coli penicillin-binding proteins 4, 5, 6 and 6b for membrane interaction. Eur. J. Biochem. 269 (2002) 5821-5829
32. Harris F., Demel R., de Kruijff B., and Phoenix D.A. An investigation into the lipid interactions of peptides corresponding to the C-terminal anchoring domains of Escherichia coli penicillin-binding proteins 4, 5 and 6. Biochim. Biophys. Acta 1415 (1998) 10-22
33. Rothbard J.B., Jessop T.C., Jones L., Goun E., Shinde R., Contag C.H., and Wender P.A. Mechanistic insights into guanidium-rich transporters entering cells. In: Langel U. (Ed). Handbook of Cell-Penetrating Peptides (2007), CRC/Taylor & Francis, Boca Raton 353-373
34. Dennison S.R., Wallace J., Harris F., and Phoenix D.A. Amphiphilic alpha-helical antimicrobial peptides and their structure/function relationships. Protein Pept. Lett. 12 (2005) 31-39
35. Deshayes S., Morris M.C., Divita G., and Heitz F. Interactions of cell-penetrating peptides with model membranes. In: Langel U. (Ed). Handbook of Cell-Penetrating Peptides (2007), CRC/Taylor & Francis, Boca Raton 139-160
36. Tiriveedhi V., and Butko P. A fluorescence spectroscopy study on the interactions of the TAT-PTD peptide with model lipid membranes. Biochemistry 46 (2007) 3888-3895
37. Dennison S.R., Harris F., and Phoenix D.A. Are oblique orientated alpha-helices used by antimicrobial peptides for membrane invasion?. Protein Pept. Lett. 12 (2005) 27-29